Blood-Borne Diseases

The FDA has approved treatment for adults and children with all genotypes of hepatitis C and compensated cirrhosis that shortens duration of treatment to 8 weeks.

In part 1 of our Q&A with Fair, we talk about his background, education, and experience, and also how the outbreak response to the current Ebola outbreak in the DRC differs from traditional disaster response.

In this outbreak, 18% of Ebola cases have been tied to health care transmission. How can we prevent this from continuing?

The target action date for the V920 investigational Ebola vaccine is set for March 14, 2020.

Although drinking water-associated outbreaks are rarely reported in the United States, they were the most commonly reported etiology for outbreaks associated with untreated ground water from 1971-2008.

Investigators observed that, when compared with the general population of Guinea, survivors of Ebola had a 5-fold increased risk of mortality over a mean of 1 year of follow-up after discharge.

As the summer comes to a close, our editorial team is looking back at the top FDA approvals of 2019 to date and looking ahead at what is left on the docket this year.

No one knows exactly why thousands of patients in dozens of states have contracted hepatitis A in recent years. In the absence of an explanation, public health officials are focusing on vaccination.

The Biomedical Advanced Research and Development Authority will contribute $23 million for Merck to continue manufacturing the Ebola vaccine over the next year.

A team of investigators review global HCV infection rates in an attempt to quantify HCV-associated cardiovascular disease.

Variances in collection and siloed efforts are hurting this outbreak response.

The research team deciphered that the nitazoxanide boosts the ability of specific viral sensors to detect Ebola when infected, which then sparks an antiviral immune response.

An independent monitoring board recommended early termination of the PALM trial after determining that 2 of the 4 experimental therapies were linked with better rates of survival.

The Ad26.ZEBOV, MVA-BN-Filo vaccine regimen will be evaluated in an open-label, single-arm study of 800 participants, including frontline health care workers.

The state has documented 2582 cases of hepatitis A in the ongoing outbreak. Health officials indicate that 98% of those cases were acquired within the state.

The new recommendations aim to limit the potentially deadly disease from infecting newborns or mothers.

August 1, 2019, marks the 1 year anniversary of the North Kivu Ebola outbreak.

From vaccines to conflict, here's an update on why this Ebola outbreak is so unique.

Dr. Tedros has accepted the World Health Organization (WHO) International Health Regulations Emergency Committee's recommendation.

The Congolese city is home to more than 2 million people and rests against the border of Rwanda, a nation that is potentially vulnerable to the spread of Ebola.

Facing an outbreak of HAV, Arizona works to collaborate across public health departments and health care facilities.

The recommendations are currently under review by US Centers for Disease Control and Prevention and the Department of Health and Human Services.

A new matrix will help prepare multiple industries to combat potential Ebola occupational exposures

The neighboring nation to the DRC has also launched ring vaccination following the confirmation of 3 travel-associated Ebola cases.

This case is the first confirmed case of Ebola that Uganda has detected during the ongoing outbreak in the neighboring Democratic Republic of the Congo.

As the DRC records 2000 cases of Ebola, Contagion® spoke with Krutika Kuppalli, MD, about how this outbreak is unique and whether there is an end in sight.

Meeting goals to eliminate HIV, viral hepatitis, and sexually transmitted infections by 2030 will require accelerated efforts, according to a progress report from the WHO.

The state will allocate an additional $650,000 that will be divided up amongst areas of need.

Initiating a model that provides testing, treatment and linkage to care for HCV in correctional facilities would improve outcomes but requires a costly investment.

The latest on this ever-changing and complex outbreak.